SOMERSET, NJ, JANUARY 30, 2013 – The Catalent Applied Drug Delivery Institute today announced the launch of the second annual Global Academic Competition for Life Science Leaders of Tomorrow, a program that aims to encourage students’ interest and knowledge of applied drug delivery technologies. The Institute welcomes the participation of university students enrolled in graduate programs related to pharmaceutical science, industrial pharmacy, drug delivery, and drug development.
“The Global Academic Competition reflects the commitment of The Institute to foster education, collaboration, and adoption of drug delivery technologies to develop better treatments for patients,” stated Kurt Nielsen, Ph.D., Senior Vice President of Research and Development at Catalent Pharma Solutions. “We are pleased that so many prominent schools have already joined the program, and look forward to more joining.”
Participating institutions includes Purdue University, St. John’s University, Rutgers University, New Jersey Institute of Technology, University of North Carolina at Chapel Hill, University of Düsseldorf, Germany, and University of Bristol, U.K. Entries from students enrolled at these and other universities are encouraged before the submission deadline on February 22, 2013.
Entries should take the form of an original review article based on topics such as drug development, delivery technologies, improving therapeutic profiles and bioavailability, pre-formulation, or on the delivery of drugs to certain patient groups such as pediatrics. Winning students will receive scholarships as well as publication and internship opportunities.
Details of the Global Academic Competition including categories, entry forms and additional information can be found at www.drugdeliveryinstitute.com.
About Catalent Applied Drug Delivery Institute
Catalent’s Applied Drug Delivery Institute was founded to serve as a link between industry and academia, advance education and training in drug delivery in academia and the industry, accelerate adoption of applied drug delivery technologies to develop better treatments and foster industry collaboration on major issues pertaining to drug development, formulation and delivery. It is pursuing a multi-tiered approach of seed funding, strategic counsel, and educational programs to advance the adoption of emerging technologies.
Catalent Pharma Solutions is the global leader in development solutions and advanced drug delivery technologies, providing world-wide clinical and commercial supply capabilities for drugs, biologics and consumer health products. With over 75 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable product supply. Catalent employs approximately 9,000 people, including over 1,000 scientists, at nearly 30 facilities across five continents and generates more than $1.6 billion in annual revenue. Catalent is headquartered in Somerset, N.J. For more information, visit www.catalent.com.
more products. better treatments. reliably supplied.™